ESR1 encodes an estrogen receptor, plays a crucial role in the occurrence and progression of breast and endometrial cancer, and is the main reason for resistance to estrogen suppression therapy (Piscuoglio et al., 2018). This evidence concerns the gene ESR1 and endometrial cancer.